Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 7.3
(-2.41%)
CNY 7.3
(-2.41%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 88.87 Million CNY | 38.93% |
| 2022 | 63.97 Million CNY | 20.75% |
| 2021 | 52.97 Million CNY | -15.56% |
| 2020 | 62.73 Million CNY | 18.78% |
| 2019 | 52.81 Million CNY | 14.82% |
| 2018 | 45.99 Million CNY | 68.96% |
| 2017 | 27.22 Million CNY | -28.89% |
| 2016 | 38.28 Million CNY | 29.12% |
| 2015 | 29.65 Million CNY | 66.69% |
| 2014 | 17.78 Million CNY | 12.91% |
| 2013 | 15.75 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 79.23 Million CNY | -10.85% |
| 2024 Q3 | 88.45 Million CNY | 7.35% |
| 2024 Q2 | 82.39 Million CNY | 3.99% |
| 2023 Q1 | 76.47 Million CNY | 19.54% |
| 2023 Q3 | 93.89 Million CNY | 0.88% |
| 2023 Q2 | 93.07 Million CNY | 21.71% |
| 2023 Q4 | 88.87 Million CNY | -5.35% |
| 2023 FY | 88.87 Million CNY | 38.93% |
| 2022 Q3 | 58.03 Million CNY | 8.08% |
| 2022 Q1 | 53.64 Million CNY | 1.25% |
| 2022 FY | 63.97 Million CNY | 20.75% |
| 2022 Q4 | 63.97 Million CNY | 10.24% |
| 2022 Q2 | 53.69 Million CNY | 0.1% |
| 2021 Q3 | 54.73 Million CNY | -3.58% |
| 2021 FY | 52.97 Million CNY | -15.56% |
| 2021 Q4 | 52.97 Million CNY | -3.22% |
| 2021 Q2 | 56.77 Million CNY | 0.84% |
| 2021 Q1 | 56.29 Million CNY | -10.26% |
| 2020 Q4 | 62.73 Million CNY | 6.07% |
| 2020 FY | 62.73 Million CNY | 18.78% |
| 2020 Q2 | 59.82 Million CNY | 2.74% |
| 2020 Q1 | 58.22 Million CNY | 10.25% |
| 2020 Q3 | 59.14 Million CNY | -1.13% |
| 2019 Q3 | 46.73 Million CNY | -8.12% |
| 2019 Q2 | 50.86 Million CNY | 77.8% |
| 2019 Q1 | 28.6 Million CNY | -37.8% |
| 2019 FY | 52.81 Million CNY | 14.82% |
| 2019 Q4 | 52.81 Million CNY | 13.01% |
| 2018 FY | 45.99 Million CNY | 68.96% |
| 2018 Q4 | 45.99 Million CNY | -2.58% |
| 2018 Q2 | 42.33 Million CNY | 15.61% |
| 2018 Q3 | 47.21 Million CNY | 11.54% |
| 2018 Q1 | 36.61 Million CNY | 34.49% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 FY | 27.22 Million CNY | -28.89% |
| 2017 Q4 | 27.22 Million CNY | -13.87% |
| 2017 Q3 | 31.6 Million CNY | -0.55% |
| 2017 Q2 | 31.78 Million CNY | 0.0% |
| 2016 FY | 38.28 Million CNY | 29.12% |
| 2016 Q4 | 38.28 Million CNY | 0.0% |
| 2015 FY | 29.65 Million CNY | 66.69% |
| 2014 FY | 17.78 Million CNY | 12.91% |
| 2013 FY | 15.75 Million CNY | 0.0% |